SBI Term Loan: RLLR: 8.15 | 7.25% - 8.45%
Canara Bank: RLLR: 8 | 7.15% - 10%
ICICI Bank: RLLR: -- | 8.5% - 9.65%
Punjab & Sind Bank: RLLR: 7.3 | 7.3% - 10.7%
Bank of Baroda: RLLR: 7.9 | 7.2% - 8.95%
Federal Bank: RLLR: -- | 8.75% - 10%
IndusInd Bank: RLLR: -- | 7.5% - 9.75%
Bank of Maharashtra: RLLR: 8.05 | 7.1% - 9.15%
Yes Bank: RLLR: -- | 7.4% - 10.54%
Karur Vysya Bank: RLLR: 8.8 | 8.5% - 10.65%

Enzyme Office Spaces leases 3.5 lakh sq ft across Bengaluru to expand managed workspace footprint

#Taxation & Finance News#India#Karnataka#Bangalore
Bangalore News Desk | Last Updated : 3rd Apr, 2026
Synopsis

Enzyme Office Spaces has expanded its commercial real estate presence in Bengaluru by leasing approximately 3.5 lakh sq ft of office space across key micro-markets including Whitefield, HSR Layout, and Hebbal. The managed workspace operator plans to develop around 5,000 seats within these centres, taking its total seating capacity in India to nearly 60,000. The newly leased portfolio is expected to generate about INR 50 crore in annual revenue. The expansion reflects sustained occupier demand for flexible and managed office solutions, particularly from startups and global capability centres. The company, which currently manages nearly 2 million sq ft across cities, has also outlined further leasing plans for the upcoming financial year.

Enzyme Office Spaces has secured lease agreements for approximately 3.5 lakh sq ft of office space in Bengaluru over the past few months, expanding its footprint across Whitefield, HSR Layout, and Hebbal, as part of its strategy to scale managed workspace operations in key commercial corridors. The newly leased assets are being developed into flexible office centres with an estimated capacity of around 5,000 seats, aimed at catering to enterprise clients, startups, and global capability centres.


The company has taken about 1.8 lakh sq ft in Whitefield, 1.5 lakh sq ft in HSR Layout, and nearly 16,000 sq ft in Hebbal, consolidating its presence across established and emerging office micro-markets in Bengaluru. These locations continue to attract a mix of technology firms and multinational occupiers, contributing to sustained leasing activity in the city's commercial real estate segment.

The expansion is projected to generate approximately INR 50 crore in annual revenue for the company. With these additions, Enzyme's total seating capacity across India is expected to increase to around 60,000 seats, reinforcing its position within the managed office space segment. The company currently operates a portfolio of nearly 2 million sq ft across major urban markets.

According to the companys leadership, the pace of leasing in Bengaluru reflects increasing demand for managed workspace solutions in strategic business districts. The new centres in Whitefield and HSR Layout are being developed as standalone facilities, while the Hebbal space is located within a larger commercial development, indicating a mix of asset strategies to cater to diverse occupier requirements.

The operator follows a leasing-led model, wherein properties are taken on long-term agreements, fitted out, and subleased as managed office solutions. Its client base includes companies such as Paytm, Vyapaar, Sugar Cosmetics, Cognite, Teachmint, Increff, and Sber Bank, reflecting a mix of domestic enterprises and multinational firms utilising flexible office formats.

Looking ahead, the company has indicated plans to lease an additional 2-2.5 lakh sq ft of office space in the next financial year, supported by continued demand for flexible workspaces. The expansion aligns with broader trends in Bengaluru's office market, where managed workspace providers are increasingly active in securing large-format leases to cater to evolving corporate real estate strategies.

The transaction highlights ongoing momentum in Bengaluru's commercial leasing market, particularly within the flexible workspace segment, as occupiers continue to prioritise scalability and operational flexibility in their office portfolios.

Have something to say? Post your comment